Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma
Authors
Keywords
-
Journal
CANCER
Volume 118, Issue 7, Pages 1856-1867
Publisher
Wiley
Online
2011-09-02
DOI
10.1002/cncr.26472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity
- (2010) Lu Fan et al. Pharmacogenetics and Genomics
- Glutathione S-transferase polymorphisms in osteosarcoma patients
- (2010) Carolina Salinas-Souza et al. Pharmacogenetics and Genomics
- Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation
- (2009) M Tanaka et al. BRITISH JOURNAL OF CANCER
- Advances in individual prediction of methotrexate toxicity: a review
- (2009) Kjeld Schmiegelow BRITISH JOURNAL OF HAEMATOLOGY
- MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer
- (2009) Ning Sun et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model
- (2009) Virginie Charasson et al. EUROPEAN JOURNAL OF CANCER
- Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2009) Eray Goekkurt et al. JOURNAL OF CLINICAL ONCOLOGY
- Methotrexate in Pediatric Osteosarcoma: Response and Toxicity in Relation to Genetic Polymorphisms and Dihydrofolate Reductase and Reduced Folate Carrier 1 Expression
- (2009) Ana Patiño-García et al. JOURNAL OF PEDIATRICS
- Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes
- (2009) Penelope A. Bradbury et al. Pharmacogenetics and Genomics
- Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
- (2009) D Caronia et al. PHARMACOGENOMICS JOURNAL
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms
- (2008) Albert Font et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients
- (2008) Suman Lal et al. CANCER SCIENCE
- Polymorphisms inABCG2,ABCC3andCNT1genes and their possible impact on chemotherapy outcome of lung cancer patients
- (2008) Phillip J. Müller et al. INTERNATIONAL JOURNAL OF CANCER
- Genetic Variation in Efflux Transporters Influences Outcome to Methotrexate Therapy in Patients with Psoriasis
- (2008) Richard B. Warren et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
- (2008) N. Pabla et al. KIDNEY INTERNATIONAL
- Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogenetics
- (2008) Ho Sup Lee et al. LEUKEMIA RESEARCH
- MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer
- (2008) Ji-hong Pan et al. RESPIRATION
- DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL
- (2007) S. Dulucq et al. BLOOD
- Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism
- (2007) Rita Turello et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started